A Cheshire business angel today invested to help a medical technology company press ahead with plans to grab a slice of a £1bn market.

Sky Medical, based at Daresbury, near Warrington, has developed a product to help combat deep vein thrombosis – blood clots in the legs.

OnPulse is an adhesive strip that sticks to the leg and stimulates muscles in the calf and foot, improving blood flow.

It is designed to treat patients who are in danger of developing DVT, for example because they are rendered immobile after an operation.

Sky Medical has secured funding through Envestors, a private investor network.

Mark Gidge, a partner at Cheshire-based Independent Capital Investments, has agreed to make an undisclosed equity investment to help bring OnPulse to market.

Sky Medical hopes to grab a slice of the £1bn DVT devices market and says independent research has proved OnPulse is more effective than existing products, which include  compression devices and blood-thinning drugs.

Mr Gidge said: “It was compelling that there needed to be a better solution to this problem than currently exists. “The product potentially has a massive upside, not just in a business sense but also in terms of the human benefit and the massive cost saving to the NHS.”

Tom Wilkins, managing director at Envestors, brokered the deal.

He said: “The investment in Sky Medical shows that investors are keen to back quality high growth businesses in the region.”

Sky Medical is expected to secure further investment through Envestors by the end of the year.

Tweet